PTS A1CNow Self-Check (4ct)

$70.89

Manage Diabetes through Telehealth with PTS A1CNow Self-Check® 

Includes HbA1C Disposable Analyzer & Tests (4/Box).

In stock

SKU: 3070 Category:

Description

Telehealth Information Sheet
Package Insert
Important Steps Guide
Target Ranges
Brochure
Sell Sheet

Unit: 1 Box
Regulatory Status: CLIA Waived / NGSP-certified / IFCC-traceable / CE-marked for self-test use
Contents: (1) A1c Now Monitor, (4) Single-Use Cartridges, (4) Blood Collectors & Shakers, (4) Lancets
Determinations: Hemoglobin A1c (Glycated Hemoglobin)
Storage Requirements: 64° – 77° F
Sample Volume: 5 uL
Processing Time: 5 minutes

 

PTS A1CNow Self-Check® provides you with a fast and easy way of obtaining accurate A1C results in your home. This innovative technology enables you to test your A1C quarterly to better maintain control of your blood glucose levels.

The A1c Now Self-Check System can make quarterly A1C testing more cost-effective and convenient for people with diabetes.  It is a disposable monitor used for the quantitative measurement of A1c using finger-stick blood samples. With one drop of blood (5uL) and just three simple steps, you will receive fast results representing your overall blood sugar management over the last 3 months.  The testing device is light-weight and portable, and testing can be easily performed in your own home.

Results are available in 5 minutes. To ensure accuracy, the A1c Now utilizes internal controls.  The monitor performs over 50 internal chemical and electronic quality control checks with each test, including checks for potential hardware or software errors, and potential reagent strip errors. An error code is reported in place of a result if any quality check does not pass.

The A1c Now test is certified by the National Glycohemoglobin Standardization Program (NGSP) and therefore traceable to the DCCT. Furthermore, the test is factory calibrated with a set of blood samples that have been quantitated by a NGSP certified laboratory using a NGSP certified method. Since in-field calibration is neither needed nor possible, the user cannot alter the accuracy of the test. Allowing for the normal variation seen with all laboratory methods, a 7% HbA1c on A1c Now will thus be, on average, the same as a 7% HbA1c on other instruments that are also calibrated to NGSP standards

A1c Now+ Includes:

1 A1c Now Monitor
4 Single-Use Cartridges
4 Blood Collectors & Shakers
4 Lancets

Key Features:

Fast

  • On-site testing and results. No waiting for lab results
  • Results in just five minutes
  • Hands-on procedure time is less than one minute
  • Affordable and easy-to-use

Easy

  • Simple, 3-step procedure
  • No calibration, no maintenance
  • No refrigeration necessary if used within four months
  • Small, compact, and battery-powered
  • Small blood sample

Accurate

  • Proven lab accuracy at 99%
  • CLIA waived
  • NGSP certified

Background

A1C, also known as glycated hemoglobin or glycosylated hemoglobin, is an effective indicator of a patient’s blood sugar control over the last two to three months. A1C is formed when glucose in the blood binds irreversibly to hemoglobin to form a stable glycated hemoglobin complex, which remains viable for 90-120 days, the normal lifespan of a red blood cell.  Only then can the A1c be eliminated as the red cells are replaced with new ones.

A1C values are directly proportional to the concentration of glucose in the blood over the full life span of the red blood cells; therefore, the values are not subject to the fluctuations that are seen with daily blood glucose monitoring.  The A1C value is an index of mean blood glucose over the past two to three months with the majority of that value weighted in the last thirty days. This bias is due to the body’s natural destruction and replacement of red blood cells. Because red blood cells are constantly being destroyed and replaced, it does not take 120 days to detect a clinically meaningful change in A1C following a significant change in mean blood glucose.

A1c testing poses challenges for both physicians and patients. Doctors are faced the difficulty of managing their patients’ testing schedules and compliance rates while patients must make time every three months to complete these tests and then wait for days to receive their results. An industry survey of 6,000 diabetic patients found that two-thirds failed to meet the ADA’s A1c target levels. However, researchers discovered that immediate access and feedback to A1c results created significant improvements in patients’ glucose levels.

The American Diabetes Association (ADA) recommends the A1c Now+ as the best method of testing to monitor a patient’s A1c and insure that they are properly managing their long-range blood sugar levels.. The A1c test should be performed every 3 months for insulin-treated patients, during treatment changes, or when blood glucose is elevated. For stable patients on oral agents, the recommended frequency is at least twice per year.

Equipment Specifications

Principle: Antibody to HbA1c, antigen conjugate that binds the antibody HbA1c, and membranes
Methodology: Microelectronic/Optics technology
Measuring Time: 5 minutes
Sample Type: Capillary, venous, or arterial blood
Sample Size: 5 ul
Dilution Kit Solution: 0.37 mL of buffered detergent solution with ferricyanide
Fingerstick Precision: 99%
Venous Precision: 99.7%
Calibration: Factory Calibrated (NGSP Certified)
Storage: 64° – 82° F

Additional information

Weight 1.0 lbs
Dimensions 4 × 8 × 5 in